Pancreatic cancer is an aggressive tumor, which is most often diagnosed in later stage. By 2017, pancreatic cancer could be the third highest cancer killer in Europe.
- Pancreatic cancer is a tumor of the pancreas, mostly involving in its exocrine region
- Globally, pancreatic cancer is the 7th most common cause of cancer-related death
- Pancreatic cancer is the 4th deadliest cancer in the Europe
- It has the highest mortality rate of many other cancers in the Europe
Pancreatic Cancer - All About the Disease, its Diagnosis and Management
Pancreatic cancer often involves its exocrine part. It grows aggressively, and often detected late. Treatment options include surgery, radiation and chemotherapy.
Pancreatic cancer often involves its exocrine part. It grows aggressively, and often detected late. Treatment options include surgery, radiation and chemotherapy.
‘Pancreatic cancer, is the seventh most common cause of cancer death. The study shows that mortality rate of pancreatic cancer is increasing in the Europe in 2017.’
Recent findings presented at United European Gastroenterology (UEG) Week 2016, convey that pancreatic cancer will become the third highest mortality rate after lung and colorectal cancer in the Europe. Pancreatic cancer death rates are increasing in many countries across the Europe, and it is determined that about 91,500 deaths will occur in 2017, compared with 91,000 from breast cancer. Time-linear prediction models were used by the research team to calculate the mortality rates until 2025, where the deaths from pancreatic cancer (111, 500) across Europe were projected to have increased by almost 50 percent since 2010 (76,000). All the countries included in the study show change in pancreatic cancer mortality rates from 20% to a stumbling 131% increase over the 15-year period.
Despite being the third highest cause of cancer-related death, the prevalence rate of pancreatic cancer across Europe is relatively small when compared with colorectal, lung and breast cancer. This demonstrates a significantly reduced outlook for the patients diagnosed with the disease which, unlike many other types of cancer, has not changed in the last 40 years.
Supportive Tissue in Tumors Actually Hinders Pancreatic Cancer
Researchers have found that fibrous tissue that was suspected of making pancreatic cancer worse could support immune system attack that slows down its progression, but not overcome it
Researchers have found that fibrous tissue that was suspected of making pancreatic cancer worse could support immune system attack that slows down its progression, but not overcome it
The World Pancreatic Cancer Day will be observed on November 17. Health experts are calling for increased awareness of the disease to allow people to be diagnosed in time for life-saving surgery. Professor Matthias Löhr, UEG pancreatic cancer specialist, explains, "Pancreatic cancer survival rate is lower than any other cancer. Consequently, it is absolutely vital that patients receive a diagnosis as early as possible to allow for surgery, which is currently the only potential for a cure."
Advertisement
Tiny Gold Particles Could Lead to a New Type of Treatment for Pancreatic Cancer
Gold nanoparticles could limit tumor growth and metastasis in a model of pancreatic cancer, revealed a new study.
Gold nanoparticles could limit tumor growth and metastasis in a model of pancreatic cancer, revealed a new study.
Advertisement
Quiz on Pancreatic Cancer
Pancreatic cancer is often diagnosed at a late stage and can be fatal. Test your knowledge on pancreatic cancer by taking this quiz.
Pancreatic cancer is often diagnosed at a late stage and can be fatal. Test your knowledge on pancreatic cancer by taking this quiz.
